Cannabis company HEXO Corp. posted a loss of -$93.3 million or -37 cents in its fiscal first quarter. Losses, adjusted for asset impairment costs and costs related to mergers and acquisitions, were -9 cents per share. The result was better than the -10 cents per share loss expected by analysts surveyed by Zacks Investment Research.
The company’s adjusted revenue for the quarter came in at $39.8 million, which fell short of the $45.4 million estimated by analysts surveyed by Zacks.
pharmaceutical, medical cannabis, marijuana
Industry PharmaceuticalsOther